Jula Inrig, Chief Medical Officer: Travere Therapeutics TVTX Sell · Filed 04/15

Trade details

Type: Insider sale
Amount: $302,524.95
Shares · price: 7,215 sh · $41.93 a share
Held after: 112,491 sh
Stock: Travere Therapeutics TVTX
Person: Jula InrigChief Medical Officer
Trade date: 26/04/14
Filed: 26/04/15
Days to filing: 1 days

Sold 6.0% of holdings

Share of holding sold: 6.0%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 03/15~05/14

Jula Inrig's recent trades

Jula InrigChief Medical Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$2.9M
44,674 sh
$2.9M
Filed 09/15
Traded 09/15
Jula InrigChief Medical Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$900K
20,000 sh
$900K
Filed 05/06
Traded 05/04
Jula InrigChief Medical Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$101.4K
2,174 sh
$101.4K
Filed 05/06
Traded 05/05
Jula InrigChief Medical Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$13.7K
311 sh
$13.7K
Filed 05/06
Traded 05/06
Jula InrigChief Medical Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$13.7K
311 sh
$13.7K
Filed 05/06
Traded 05/06

Jula Inrig, Chief Officer — sold $302.5K of Travere Therapeutics TVTX · 6.0% of holdings · 10b5-1 plan | Whalegun